Calcimimetic

Calcimimetic[edit | edit source]

Calcimimetics are a class of drugs designed to simulate the action of calcium on various tissues. They achieve this through the allosteric activation of the calcium-sensing receptor, which is expressed in several human organ tissues. Primarily used to treat hyperparathyroidism, calcimimetics like Cinacalcet play a crucial role in managing calcium levels in the body.

Mechanism of Action[edit | edit source]

Calcimimetics function by mimicking the role of calcium at certain receptors in the body, particularly:

Calcium-sensing Receptors: Found on the parathyroid gland, these receptors play a critical role in maintaining calcium homeostasis. When activated by calcimimetics, the sensitivity of these receptors to calcium is heightened.
Parathyroid Hormone (PTH) Regulation: Due to the increased sensitivity of calcium-sensing receptors, there's a perceived sufficiency in calcium levels, leading to a reduction in PTH secretion.

Cinacalcet[edit | edit source]

Cinacalcet (brand name: Sensipar) is the sole representative of this drug class. By mimicking calcium at the parathyroid hormone receptor, Cinacalcet increases the sensitivity of the calcium-sensing receptors on the parathyroid gland. This mechanism ultimately results in:

Decreased secretion of PTH
Lower observed calcium levels in the bloodstream

Therapeutic Use[edit | edit source]

Calcimimetics, including Cinacalcet, are primarily indicated for:

Hyperparathyroidism Treatment: To address excessive production of parathyroid hormone, often seen in patients with chronic kidney disease or parathyroid carcinoma.
Concurrent Therapy: Calcimimetics can be used alongside vitamin D therapies for a more comprehensive approach to treating disorders of calcium metabolism.

Side Effects[edit | edit source]

Like all medications, calcimimetics come with potential side effects. Some of the most common adverse reactions include:

Nausea and Vomiting: Digestive disturbances can be a common occurrence.
Hypocalcemia: Abnormally low levels of calcium in the blood, which can lead to muscle cramps, numbness, and seizures.
Adynamic Bone Disease: This can manifest if iPTH levels plummet below 100pg/mL, leading to a decrease in bone turnover.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.